The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 351:829-831 August 19, 2004 Number 8
NextNext

Treatment of Advanced Head and Neck Cancer

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Cooper, J. S.
-Related Article
by Bernier, J.
-PubMed Citation
To the Editor: In our clinic, we use postoperative radiotherapy for advanced head and neck carcinoma. For nonoperable tumors, we use the toxic regimen of radiochemotherapy described in the May 6 issue by Cooper et al. in their report on the Radiation Therapy Oncology Group (RTOG) trial1 and by Bernier et al. in their report on the European Organization for Research and Treatment of Cancer (EORTC) trial,2 with radiation doses of 66 to 70 Gy. Between 1998 and 2002, we treated 197 patients with advanced, nonoperable head and neck cancer with the use of radiochemotherapy alone. We performed a retrospective . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.